BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2731314)

  • 1. Intracellular metabolites of cisplatin in the rat kidney.
    Mistry P; Lee C; McBrien DC
    Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 Jul; 34(13):2363-9. PubMed ID: 4040367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
    Mason RW; Hogg SJ; Edwards IR
    Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney.
    Mistry P; Merazga Y; Spargo DJ; Riley PA; McBrien DC
    Cancer Chemother Pharmacol; 1991; 28(4):277-82. PubMed ID: 1879045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and metabolism of cisplatin by rat kidney.
    Safirstein R; Miller P; Guttenplan JB
    Kidney Int; 1984 May; 25(5):753-8. PubMed ID: 6540826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1984 Oct; 33(19):3063-70. PubMed ID: 6541482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.
    Stewart DJ; Dulberg C; Molepo JM; Mikhael NZ; Montpetit VA; Redmond MD; Goel R
    Cancer Chemother Pharmacol; 1994; 34(1):14-22. PubMed ID: 8174197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N; Hotta K; Yamamura H; Ogata H
    Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
    Hanigan MH; Gallagher BC; Taylor PT
    Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats.
    Zicca A; Cafaggi S; Mariggiò MA; Vannozzi MO; Ottone M; Bocchini V; Caviglioli G; Viale M
    Eur J Pharmacol; 2002 May; 442(3):265-72. PubMed ID: 12065080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
    Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA
    J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J; Litterst CL
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
    Mason R; Hogg S; Edwards IR
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of cis-platinum with cellular zinc and copper in rat liver and kidney tissues.
    Sharma RP
    Pharmacol Res Commun; 1985 Feb; 17(2):197-206. PubMed ID: 4039454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity.
    Litterst CL; Schweitzer VG
    Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J; Litterst CL
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of platinum with metallothionein-like ligands in the rat kidney after administration of cis-dichlorodiammine platinum II.
    Mason R; Edwards IR; McLaren SJ
    Chem Biol Interact; 1984 Apr; 49(1-2):165-76. PubMed ID: 6539175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin.
    Safirstein R; Daye M; Guttenplan JB
    Cancer Lett; 1983 Apr; 18(3):329-38. PubMed ID: 6682696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.
    Hanada K; Nagai N; Ogata H
    J Chromatogr B Biomed Appl; 1995 Jan; 663(1):181-6. PubMed ID: 7704209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.